S&P 500   4,686.21 (+2.06%)
DOW   35,741.64 (+1.46%)
QQQ   397.64 (+2.96%)
AAPL   171.08 (+3.48%)
MSFT   335.05 (+2.72%)
FB   324.00 (+1.93%)
GOOGL   2,944.11 (+2.83%)
AMZN   3,532.00 (+3.05%)
TSLA   1,042.40 (+3.31%)
NVDA   318.82 (+6.14%)
BABA   125.75 (+1.74%)
NIO   33.32 (+3.03%)
CGC   10.92 (+7.59%)
AMD   143.46 (+3.16%)
GE   97.89 (+1.96%)
MU   86.65 (+5.09%)
T   23.13 (-0.64%)
F   19.95 (+3.80%)
DIS   150.47 (+0.07%)
PFE   51.57 (+0.17%)
AMC   31.30 (+8.72%)
ACB   6.42 (+7.54%)
BA   210.10 (+2.05%)
S&P 500   4,686.21 (+2.06%)
DOW   35,741.64 (+1.46%)
QQQ   397.64 (+2.96%)
AAPL   171.08 (+3.48%)
MSFT   335.05 (+2.72%)
FB   324.00 (+1.93%)
GOOGL   2,944.11 (+2.83%)
AMZN   3,532.00 (+3.05%)
TSLA   1,042.40 (+3.31%)
NVDA   318.82 (+6.14%)
BABA   125.75 (+1.74%)
NIO   33.32 (+3.03%)
CGC   10.92 (+7.59%)
AMD   143.46 (+3.16%)
GE   97.89 (+1.96%)
MU   86.65 (+5.09%)
T   23.13 (-0.64%)
F   19.95 (+3.80%)
DIS   150.47 (+0.07%)
PFE   51.57 (+0.17%)
AMC   31.30 (+8.72%)
ACB   6.42 (+7.54%)
BA   210.10 (+2.05%)
S&P 500   4,686.21 (+2.06%)
DOW   35,741.64 (+1.46%)
QQQ   397.64 (+2.96%)
AAPL   171.08 (+3.48%)
MSFT   335.05 (+2.72%)
FB   324.00 (+1.93%)
GOOGL   2,944.11 (+2.83%)
AMZN   3,532.00 (+3.05%)
TSLA   1,042.40 (+3.31%)
NVDA   318.82 (+6.14%)
BABA   125.75 (+1.74%)
NIO   33.32 (+3.03%)
CGC   10.92 (+7.59%)
AMD   143.46 (+3.16%)
GE   97.89 (+1.96%)
MU   86.65 (+5.09%)
T   23.13 (-0.64%)
F   19.95 (+3.80%)
DIS   150.47 (+0.07%)
PFE   51.57 (+0.17%)
AMC   31.30 (+8.72%)
ACB   6.42 (+7.54%)
BA   210.10 (+2.05%)
S&P 500   4,686.21 (+2.06%)
DOW   35,741.64 (+1.46%)
QQQ   397.64 (+2.96%)
AAPL   171.08 (+3.48%)
MSFT   335.05 (+2.72%)
FB   324.00 (+1.93%)
GOOGL   2,944.11 (+2.83%)
AMZN   3,532.00 (+3.05%)
TSLA   1,042.40 (+3.31%)
NVDA   318.82 (+6.14%)
BABA   125.75 (+1.74%)
NIO   33.32 (+3.03%)
CGC   10.92 (+7.59%)
AMD   143.46 (+3.16%)
GE   97.89 (+1.96%)
MU   86.65 (+5.09%)
T   23.13 (-0.64%)
F   19.95 (+3.80%)
DIS   150.47 (+0.07%)
PFE   51.57 (+0.17%)
AMC   31.30 (+8.72%)
ACB   6.42 (+7.54%)
BA   210.10 (+2.05%)
NASDAQ:SOLY

Soliton Stock Forecast, Price & News

$20.32
+0.21 (+1.04%)
(As of 12/7/2021 12:16 PM ET)
Add
Compare
Today's Range
$20.20
$20.32
50-Day Range
$20.11
$21.23
52-Week Range
$7.40
$22.55
Volume
222 shs
Average Volume
335,019 shs
Market Capitalization
$438.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.19
30 days | 90 days | 365 days | Advanced Chart
Receive SOLY News and Ratings via Email

Sign-up to receive the latest news and ratings for Soliton and its competitors with MarketBeat's FREE daily newsletter.


Soliton logo

About Soliton

Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

Headlines

Soliton, Inc. 8-K Aug. 6, 2021 4:28 PM - Seeking Alpha
August 8, 2021 |  seekingalpha.com
Soliton, Inc. Common Stock (SOLY)
July 30, 2021 |  nasdaq.com
Form DEFM14A Soliton, Inc. - StreetInsider.com
June 15, 2021 |  streetinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SOLY
Fax
N/A
Employees
14
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.99 per share

Profitability

Net Income
$-14.54 million
Pretax Margin
-4,831.89%

Debt

Price-To-Earnings

Miscellaneous

Free Float
19,005,000
Market Cap
$438.85 million
Optionable
Not Optionable

Company Calendar

Last Earnings
8/12/2021
Today
12/07/2021
Next Earnings (Estimated)
12/09/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.62 out of 5 stars

Medical Sector

1015th out of 1,394 stocks

Surgical & Medical Instruments Industry

105th out of 126 stocks

Analyst Opinion: 2.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -












Soliton (NASDAQ:SOLY) Frequently Asked Questions

Is Soliton a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Soliton in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Soliton stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SOLY, but not buy additional shares or sell existing shares.
View analyst ratings for Soliton
or view top-rated stocks.

How has Soliton's stock been impacted by COVID-19?

Soliton's stock was trading at $10.66 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SOLY shares have increased by 90.6% and is now trading at $20.32.
View which stocks have been most impacted by COVID-19
.

When is Soliton's next earnings date?

Soliton is scheduled to release its next quarterly earnings announcement on Thursday, December 9th 2021.
View our earnings forecast for Soliton
.

How were Soliton's earnings last quarter?

Soliton, Inc. (NASDAQ:SOLY) issued its quarterly earnings data on Thursday, August, 12th. The company reported ($0.37) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07.
View Soliton's earnings history
.

What price target have analysts set for SOLY?

3 brokers have issued 1-year price targets for Soliton's stock. Their forecasts range from $22.60 to $25.00. On average, they anticipate Soliton's stock price to reach $23.80 in the next twelve months. This suggests a possible upside of 17.1% from the stock's current price.
View analysts' price targets for Soliton
or view top-rated stocks among Wall Street analysts.

Who are Soliton's key executives?

Soliton's management team includes the following people:
  • Bradley A. Hauser, President, Chief Executive Officer & Director
  • Joseph D. Tanner, Chief Operating Officer
  • Lori Bisson, Chief Financial Officer, Secretary & Executive VP
  • Christopher Capelli, Vice Chairman & Chief Science Officer
  • Mary Stoll, Senior Director-Clinical Development

What other stocks do shareholders of Soliton own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soliton investors own include Cronos Group (CRON), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), AbbVie (ABBV), Aurora Cannabis (ACB), (CGC), Micron Technology (MU), Square (SQ) and Verizon Communications (VZ).

What is Soliton's stock symbol?

Soliton trades on the NASDAQ under the ticker symbol "SOLY."

Who are Soliton's major shareholders?

Soliton's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.39%), Polar Asset Management Partners Inc. (2.63%), Millennium Management LLC (2.29%), Alpine Associates Management Inc. (1.46%), Candriam Luxembourg S.C.A. (1.11%) and Morgan Stanley (1.07%).
View institutional ownership trends for Soliton
.

Which major investors are selling Soliton stock?

SOLY stock was sold by a variety of institutional investors in the last quarter, including Mint Tower Capital Management B.V., Citigroup Inc., Goldman Sachs Group Inc., California State Teachers Retirement System, and Advisor Group Holdings Inc..
View insider buying and selling activity for Soliton
or view top insider-selling stocks.

Which major investors are buying Soliton stock?

SOLY stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Alpine Associates Management Inc., Candriam Luxembourg S.C.A., BlackRock Inc., Marshall Wace LLP, IndexIQ Advisors LLC, Syquant Capital Sas, and Gabelli Funds LLC.
View insider buying and selling activity for Soliton
or or view top insider-buying stocks.

How do I buy shares of Soliton?

Shares of SOLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Soliton's stock price today?

One share of SOLY stock can currently be purchased for approximately $20.32.

How much money does Soliton make?

Soliton has a market capitalization of $438.85 million. The company earns $-14.54 million in net income (profit) each year or ($1.01) on an earnings per share basis.

How many employees does Soliton have?

Soliton employs 14 workers across the globe.

What is Soliton's official website?

The official website for Soliton is www.soliton.com.

Where are Soliton's headquarters?

Soliton is headquartered at 5304 ASHBROOK DRIVE, HOUSTON TX, 77081.

How can I contact Soliton?

Soliton's mailing address is 5304 ASHBROOK DRIVE, HOUSTON TX, 77081. The company can be reached via phone at (844) 705-4866 or via email at [email protected].


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.